255 related articles for article (PubMed ID: 21926465)
1. TCR-dependent transformation of mature memory phenotype T cells in mice.
Wang X; Werneck MB; Wilson BG; Kim HJ; Kluk MJ; Thom CS; Wischhusen JW; Evans JA; Jesneck JL; Nguyen P; Sansam CG; Cantor H; Roberts CW
J Clin Invest; 2011 Oct; 121(10):3834-45. PubMed ID: 21926465
[TBL] [Abstract][Full Text] [Related]
2. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.
Burger ML; Xue L; Sun Y; Kang C; Winoto A
Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967
[TBL] [Abstract][Full Text] [Related]
3. Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.
Carras S; Chartoire D; Mareschal S; Heiblig M; Marçais A; Robinot R; Urb M; Pommier RM; Julia E; Chebel A; Verney A; Bertheau C; Bardel E; Fezelot C; Courtois L; Lours C; Bouska A; Sharma S; Lefebvre C; Rouault JP; Sibon D; Ferrari A; Iqbal J; de Leval L; Gaulard P; Traverse-Glehen A; Sujobert P; Blery M; Salles G; Walzer T; Bachy E; Genestier L
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34043588
[TBL] [Abstract][Full Text] [Related]
4. 'Normal counterparts' of nodal peripheral T-cell lymphoma.
Rüdiger T; Geissinger E; Müller-Hermelink HK
Hematol Oncol; 2006 Dec; 24(4):175-80. PubMed ID: 16783841
[TBL] [Abstract][Full Text] [Related]
5. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
[TBL] [Abstract][Full Text] [Related]
6. p57 regulates T-cell development and prevents lymphomagenesis by balancing p53 activity and pre-TCR signaling.
Matsumoto A; Takeishi S; Nakayama KI
Blood; 2014 May; 123(22):3429-39. PubMed ID: 24652995
[TBL] [Abstract][Full Text] [Related]
7. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC; Leonard WJ; Kelly JA
Blood; 2008 Jan; 111(1):344-50. PubMed ID: 17890450
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell.
Serwold T; Hochedlinger K; Swindle J; Hedgpeth J; Jaenisch R; Weissman IL
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18939-43. PubMed ID: 20956329
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525
[TBL] [Abstract][Full Text] [Related]
10. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
Högstrand K; Grandien A
Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
[TBL] [Abstract][Full Text] [Related]
11. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
Swamy M; Pathak S; Grzes KM; Damerow S; Sinclair LV; van Aalten DM; Cantrell DA
Nat Immunol; 2016 Jun; 17(6):712-20. PubMed ID: 27111141
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Kobzdej M; Matuszyk J; Strzadala L
Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
[TBL] [Abstract][Full Text] [Related]
13. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.
Johnson KG; LeRoy FG; Borysiewicz LK; Matthews RJ
J Immunol; 1999 Apr; 162(7):3802-13. PubMed ID: 10201897
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
Wilson BG; Wang X; Shen X; McKenna ES; Lemieux ME; Cho YJ; Koellhoffer EC; Pomeroy SL; Orkin SH; Roberts CW
Cancer Cell; 2010 Oct; 18(4):316-28. PubMed ID: 20951942
[TBL] [Abstract][Full Text] [Related]
15. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells.
Guy CS; Vignali KM; Temirov J; Bettini ML; Overacre AE; Smeltzer M; Zhang H; Huppa JB; Tsai YH; Lobry C; Xie J; Dempsey PJ; Crawford HC; Aifantis I; Davis MM; Vignali DA
Nat Immunol; 2013 Mar; 14(3):262-70. PubMed ID: 23377202
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
17. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
18. Thymic-specific regulation of TCR signaling by Tespa1.
Lyu J; Wang P; Xu T; Shen Y; Cui Z; Zheng M; Fu G; Lu L
Cell Mol Immunol; 2019 Dec; 16(12):897-907. PubMed ID: 31316154
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.
Gramling MW; Eischen CM
Cell Death Differ; 2012 Jul; 19(7):1220-7. PubMed ID: 22301919
[TBL] [Abstract][Full Text] [Related]
20. CD1d-restricted peripheral T cell lymphoma in mice and humans.
Bachy E; Urb M; Chandra S; Robinot R; Bricard G; de Bernard S; Traverse-Glehen A; Gazzo S; Blond O; Khurana A; Baseggio L; Heavican T; Ffrench M; Crispatzu G; Mondière P; Schrader A; Taillardet M; Thaunat O; Martin N; Dalle S; Le Garff-Tavernier M; Salles G; Lachuer J; Hermine O; Asnafi V; Roussel M; Lamy T; Herling M; Iqbal J; Buffat L; Marche PN; Gaulard P; Kronenberg M; Defrance T; Genestier L
J Exp Med; 2016 May; 213(5):841-57. PubMed ID: 27069116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
